IDEXX Laboratories, Inc. (IDXX) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
IDEXX Laboratories, Inc. (IDXX) Bundle
Gain insight into your IDEXX Laboratories, Inc. (IDXX) valuation analysis using our sophisticated DCF Calculator! This Excel template comes preloaded with authentic (IDXX) data, enabling you to adjust forecasts and assumptions to accurately determine the intrinsic value of IDEXX Laboratories, Inc.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,406.9 | 2,706.7 | 3,215.4 | 3,367.3 | 3,661.0 | 4,070.0 | 4,524.8 | 5,030.4 | 5,592.4 | 6,217.3 |
| Revenue Growth, % | 0 | 12.45 | 18.79 | 4.73 | 8.72 | 11.17 | 11.17 | 11.17 | 11.17 | 11.17 |
| EBITDA | 643.7 | 793.8 | 1,039.9 | 1,014.5 | 1,217.7 | 1,235.7 | 1,373.7 | 1,527.2 | 1,697.9 | 1,887.6 |
| EBITDA, % | 26.74 | 29.33 | 32.34 | 30.13 | 33.26 | 30.36 | 30.36 | 30.36 | 30.36 | 30.36 |
| Depreciation | 88.0 | 96.0 | 104.6 | 111.9 | 114.9 | 137.7 | 153.1 | 170.2 | 189.2 | 210.4 |
| Depreciation, % | 3.66 | 3.55 | 3.25 | 3.32 | 3.14 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 |
| EBIT | 555.7 | 697.8 | 935.3 | 902.6 | 1,102.8 | 1,097.9 | 1,220.6 | 1,357.0 | 1,508.6 | 1,677.2 |
| EBIT, % | 23.09 | 25.78 | 29.09 | 26.81 | 30.12 | 26.98 | 26.98 | 26.98 | 26.98 | 26.98 |
| Total Cash | 90.3 | 383.9 | 144.5 | 112.5 | 453.9 | 310.7 | 345.4 | 384.0 | 426.9 | 474.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 307.5 | 374.7 | 425.6 | 490.9 | 529.5 | 560.8 | 623.5 | 693.2 | 770.6 | 856.7 |
| Account Receivables, % | 12.78 | 13.85 | 13.24 | 14.58 | 14.46 | 13.78 | 13.78 | 13.78 | 13.78 | 13.78 |
| Inventories | 195.0 | 209.9 | 269.0 | 367.8 | 380.3 | 370.7 | 412.1 | 458.1 | 509.3 | 566.2 |
| Inventories, % | 8.1 | 7.75 | 8.37 | 10.92 | 10.39 | 9.11 | 9.11 | 9.11 | 9.11 | 9.11 |
| Accounts Payable | 72.2 | 74.6 | 116.1 | 110.2 | 110.6 | 127.5 | 141.7 | 157.6 | 175.2 | 194.7 |
| Accounts Payable, % | 3 | 2.75 | 3.61 | 3.27 | 3.02 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 |
| Capital Expenditure | -155.2 | -107.6 | -119.5 | -148.8 | -133.6 | -180.8 | -201.0 | -223.5 | -248.5 | -276.2 |
| Capital Expenditure, % | -6.45 | -3.98 | -3.72 | -4.42 | -3.65 | -4.44 | -4.44 | -4.44 | -4.44 | -4.44 |
| Tax Rate, % | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 |
| EBITAT | 455.1 | 613.3 | 771.8 | 712.8 | 878.2 | 902.3 | 1,003.1 | 1,115.2 | 1,239.8 | 1,378.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -42.4 | 521.9 | 688.4 | 505.8 | 808.8 | 854.4 | 865.4 | 962.1 | 1,069.6 | 1,189.1 |
| WACC, % | 10.64 | 10.65 | 10.64 | 10.64 | 10.64 | 10.64 | 10.64 | 10.64 | 10.64 | 10.64 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 3,620.3 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 1,237 | |||||||||
| Terminal Value | 18,621 | |||||||||
| Present Terminal Value | 11,231 | |||||||||
| Enterprise Value | 14,851 | |||||||||
| Net Debt | 613 | |||||||||
| Equity Value | 14,238 | |||||||||
| Diluted Shares Outstanding, MM | 84 | |||||||||
| Equity Value Per Share | 169.54 |
What You Will Get
- Editable Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to generate various scenarios.
- Real-World Data: IDEXX Laboratories, Inc.'s (IDXX) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Accurate IDEXX Financials: Gain access to reliable pre-loaded historical data and future forecasts.
- Adjustable Forecast Parameters: Modify highlighted fields for WACC, growth rates, and profit margins.
- Real-Time Calculations: Instant updates to DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries for visualizing your valuation findings.
- Suitable for All Levels: A straightforward, intuitive layout designed for investors, CFOs, and consultants alike.
How It Works
- Download the Template: Gain immediate access to the Excel-based IDXX DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically recalculates IDXX Laboratories’ intrinsic value.
- Test Scenarios: Explore various assumptions to assess potential valuation changes.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for IDEXX Laboratories, Inc. (IDXX)?
- Designed for Experts: A sophisticated tool utilized by veterinarians, analysts, and healthcare consultants.
- Accurate Data: IDEXX's historical and projected financials are preloaded for precise analysis.
- Flexible Scenario Analysis: Easily test various forecasts and assumptions to assess different outcomes.
- Comprehensive Outputs: Automatically calculates intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the calculation process.
Who Should Use This Product?
- Investors: Accurately assess IDEXX Laboratories, Inc.'s (IDXX) fair value prior to making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis tailored to IDEXX Laboratories.
- Consultants: Easily customize the template for valuation reports specific to IDEXX Laboratories' clients.
- Entrepreneurs: Acquire knowledge on financial modeling practices employed by leading companies like IDEXX Laboratories.
- Educators: Implement it as a teaching resource to illustrate valuation techniques relevant to IDEXX Laboratories.
What the Template Contains
- Historical Data: Includes IDEXX Laboratories’ past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate IDEXX Laboratories’ intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of IDEXX Laboratories’ financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.